Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
2.
Neurotoxicology ; 73: 183-187, 2019 07.
Artigo em Inglês | MEDLINE | ID: mdl-30974132

RESUMO

Seizures are a recognized and potentially serious complication of recreational drug use. This study examined a large international data set of presentations to Emergency Departments with acute recreational drug toxicity, the European Drug Emergencies Plus (Euro-DEN Plus) Network, to compare presentations with and without seizures and estimate incidence and associated drugs. Amongst 23,947 presentations between January 2014 and December 2017, there were 1013 (4.2%) with reported seizures. Clinical and demographic features were similar between individuals who had a seizure and those who did not, although rates of coma, cardiac arrest, intubation, intensive care admission, and death were significantly higher in those with seizures. There was a significant association between specific drugs and a higher seizure incidence, including fentanyl (odds ratio 2.63, 95% confidence interval 1.20-5.80), and synthetic cannabinoids (OR 2.90, 95% CI 2.19-3.84). Other drugs were associated with a lower seizure incidence, including heroin (OR 0.46, 95% CI 0.35-0.61), clonazepam (OR 0.22, 95% CI 0.06-0.91), and cannabis (OR 0.65, 95% CI 0.50-0.86). This substantiates observations that the synthetic cannabinoids as a group of novel psychoactive substances are clinically different in consequence of intoxication than cannabis, and that individuals who suffer a seizure in the context of recreational drug intoxication are likely to have worse outcomes overall. Utilising this information of what substances have a greater risk of seizures, could provide tailored harm reduction and education strategies to users to reduce the risk of seizures and their associated complications.


Assuntos
Drogas Ilícitas/efeitos adversos , Psicotrópicos/efeitos adversos , Convulsões/induzido quimicamente , Convulsões/epidemiologia , Transtornos Relacionados ao Uso de Substâncias/epidemiologia , Adulto , Temperatura Corporal/efeitos dos fármacos , Canabinoides/efeitos adversos , Canabinoides/síntese química , Europa (Continente)/epidemiologia , Feminino , Hemodinâmica/efeitos dos fármacos , Humanos , Drogas Ilícitas/síntese química , Incidência , Masculino , Antagonistas de Entorpecentes/efeitos adversos , Transtornos Relacionados ao Uso de Opioides/epidemiologia , Prognóstico , Psicotrópicos/síntese química , Respiração/efeitos dos fármacos , Medição de Risco , Fatores de Risco , Convulsões/diagnóstico , Convulsões/fisiopatologia , Transtornos Relacionados ao Uso de Substâncias/diagnóstico , Transtornos Relacionados ao Uso de Substâncias/fisiopatologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA